Malaria treatment and policy in three regions in Nigeria: The role of patent medicine vendors.
暂无分享,去创建一个
D. Peters | G. Bloom | O. Oladepo | A. Lawal | W. Brieger | K. Salami | F. Oshiname | B. Ofi | B. Adeoye | M. Oladepo | O. Ogunbemi
[1] David L. Smith,et al. Will a global subsidy of new antimalarials delay the emergence of resistance and save lives? , 2006, Health affairs.
[2] A. Okhamafe,et al. A survey of anti-malarial activity during pregnancy, and children's malaria care-seeking behaviour in two Nigerian rural communities , 2006, Scandinavian journal of infectious diseases.
[3] W. Brieger,et al. Consumer Response and Satisfaction to Prepackaged Antimalarial Drugs for Children in ABA, Nigeria , 2004, International quarterly of community health education.
[4] G. Tetteh,et al. Rapid Assessment of Antimalarial Drug Availability and Use in Nigeria, February-March 2004 , 2005 .
[5] A. Juels,et al. Making Antimalarial Agents Available in Africa , 2005 .
[6] C. Plowe,et al. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[7] Oladimeji Oladepo,et al. Interactions between patent medicine vendors and customers in urban and rural Nigeria. , 2004, Health policy and planning.
[8] Nigeria.,et al. Nigeria Demographic and Health Survey 2008 , 2004 .
[9] G. Greer,et al. Improving management of childhood malaria in Nigeria and Uganda by improving practices of patent medicine vendors. , 2004 .
[10] I. Ajayi,et al. The Role of Patent Medicine Sellers in Home Management of Childhood Malaria: A Situational Analysis of Experience in Rural Nigeria , 2002 .
[11] C. O. Akinlade,et al. Treatment of childhood fevers and other illnesses in three rural Nigerian communities. , 2001, Journal of tropical pediatrics.
[12] O. Shakoor,et al. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies , 2001, The Lancet.
[13] W. Brieger,et al. Urban malaria treatment behaviour in the context of low levels of malaria transmission in Lagos, Nigeria. , 2001, African journal of medicine and medical sciences.
[14] P. Huovinen,et al. Drug Resistance Updates , 2000, BMJ : British Medical Journal.
[15] A. Ojuawo,et al. Treatment of diarrhoea by proprietary-medicine vendors. , 1993, Nigerian journal of paediatrics.
[16] C. Leighton,et al. Economic impacts of malaria in Kenya and Nigeria. , 1993 .